Natoli Roman M, Skaalure Stacey, Bijlani Shweta, Chen Ke X, Hu Jerry, Athanasiou Kyriacos A
Rice University, Houston, and Baylor College of Medicine, Houston, Texas, USA.
Arthritis Rheum. 2010 Apr;62(4):1097-107. doi: 10.1002/art.27313.
Significant collagen content and tensile properties are difficult to achieve in tissue-engineered articular cartilage. The aim of this study was to investigate whether treating developing tissue-engineered cartilage constructs with modulators of intracellular Na(+) or Ca(2+) could increase collagen concentration and construct tensile properties.
Inhibitors of Na(+) ion transporters and stimulators of intracellular Ca(2+) were investigated for their ability to affect articular cartilage development in a scaffoldless, 3-dimensional chondrocyte culture. Using a systematic approach, we applied ouabain (Na(+)/K(+)-ATPase inhibitor), bumetanide (Na(+)/K(+)/2Cl(-) tritransporter inhibitor), histamine (cAMP activator), and ionomycin (a Ca(2+) ionophore) to tissue-engineered constructs for 1 hour daily on days 10-14 of culture and examined the constructs at 2 weeks or 4 weeks. The gross morphology, biochemical content, and compressive and tensile mechanical properties of the constructs were assayed.
The results of these experiments showed that 20 microM ouabain, 0.3 microM ionomycin, or their combination increased the tensile modulus by 40-95% compared with untreated controls and resulted in an increased amount of collagen normalized to construct wet weight. In constructs exposed to ouabain, the increased percentage of collagen per construct wet weight was secondary to decreased glycosaminoglycan production on a per-cell basis. Treatment with 20 microM ouabain also increased the ultimate tensile strength of neo-tissue by 56-86% at 4 weeks. Other construct properties, such as construct growth and type I collagen production, were affected differently by Na(+) modulation with ouabain versus Ca(2+) modulation with ionomycin.
These data are the first to show that treatments known to alter intracellular ion concentrations are a viable method for increasing the mechanical properties of engineered articular cartilage and identifying potentially important relationships to hydrostatic pressure mechanotransduction. Ouabain and ionomycin may be useful pharmacologic agents for increasing tensile integrity and directing construct maturation.
在组织工程化关节软骨中难以实现显著的胶原蛋白含量和拉伸性能。本研究的目的是调查用细胞内钠离子或钙离子调节剂处理正在发育的组织工程化软骨构建体是否能增加胶原蛋白浓度和构建体的拉伸性能。
研究了钠离子转运体抑制剂和细胞内钙离子刺激剂在无支架三维软骨细胞培养中影响关节软骨发育的能力。我们采用系统方法,在培养的第10至14天,每天将哇巴因(钠/钾-ATP酶抑制剂)、布美他尼(钠/钾/2氯同向转运体抑制剂)、组胺(环磷酸腺苷激活剂)和离子霉素(钙离子载体)应用于组织工程构建体1小时,并在2周或4周时检查构建体。测定了构建体的大体形态、生化成分以及压缩和拉伸力学性能。
这些实验结果表明,与未处理的对照相比,20微摩尔哇巴因、0.3微摩尔离子霉素或它们的组合使拉伸模量提高了40 - 95%,并导致以构建体湿重归一化后的胶原蛋白量增加。在暴露于哇巴因的构建体中,每个构建体湿重中胶原蛋白增加的百分比是由于每个细胞的糖胺聚糖产量降低所致。用20微摩尔哇巴因处理在4周时还使新组织的极限拉伸强度提高了56 - 86%。其他构建体特性,如构建体生长和I型胶原蛋白产生,用哇巴因进行钠调节与用离子霉素进行钙调节的影响不同。
这些数据首次表明,已知可改变细胞内离子浓度的处理方法是提高工程化关节软骨力学性能以及确定与静水压力机械转导潜在重要关系的可行方法。哇巴因和离子霉素可能是用于提高拉伸完整性和指导构建体成熟的有用药物。